Cargando…
Dose‐dependent elevation in amylase and lipase in response to teduglutide administration
Teduglutide has been used for patients with short bowel syndrome. Teduglutide can be a dose‐dependent triggering factor to increased amylase and lipase. Serum amylase and lipase levels should be monitored routinely for patients on teduglutide, and they should be screened before the initiation of tre...
Autores principales: | Lee, Joshua, Kim, Myoung, Kim, Dong Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509918/ https://www.ncbi.nlm.nih.gov/pubmed/31110724 http://dx.doi.org/10.1002/ccr3.2127 |
Ejemplares similares
-
Hypothyroidism with elevated pancreatic amylase and lipase without clinical symptoms: A case report
por: Xu, Yong-Wei, et al.
Publicado: (2020) -
Teduglutide in amyloidosis‐associated intestinal failure
por: Luhn, Clara, et al.
Publicado: (2023) -
Bridging intestinal failure with Teduglutide – A case report
por: Schlager, Lukas, et al.
Publicado: (2021) -
The Utility of Endoscopic Ultrasound in Patients with Isolated Elevations in Serum Amylase and/or Lipase
por: Sitaraman, Lalitha M., et al.
Publicado: (2019) -
Short Bowel Syndrome and Kidney Transplantation: Challenges, Outcomes, and the Use of Teduglutide
por: Abou Diwan, Elizabeth, et al.
Publicado: (2020)